logo
Healthcare's Innovation Problem: We're Rebranding The Past And Calling It Progress

Healthcare's Innovation Problem: We're Rebranding The Past And Calling It Progress

Forbes05-05-2025

In healthcare, what's often hailed as groundbreaking is, in reality, a repackaging of ideas we've seen before.
Over the past two decades, I've watched healthcare's innovation cycle become increasingly dominated by hype. We celebrate new terminology, fresh branding, and bold claims. Yet, beneath the surface, many of these 'new' solutions are iterations—or direct descendants—of approaches pioneered decades ago. That's not a criticism. It's a call to humility.
Take the much-discussed concept of social determinants of health. Over the past few years, the healthcare industry has collectively woken up to the idea that housing, nutrition, transportation, and social support impact health outcomes. You'd be hard-pressed to attend a conference or read a whitepaper that doesn't mention this concept.
But here's the truth: we've been here before.
In the 1980s, SCAN—then a fledgling health plan—was a lead participant in the Social HMO demonstration project, a Medicare-funded initiative that integrated medical care with social supports. The idea was simple but powerful: that care doesn't stop at the clinic door. Participants received benefits like homemaker services, personal care, adult day care, respite services, and medical transportation. These interventions weren't framed as 'social determinants'—but they were exactly that. We had a name for it then, too: common sense.
Or consider value-based care. It's heralded as a transformative movement in healthcare—a shift away from volume and toward value. But again, this isn't new. Organizations like Kaiser Permanente, Healthcare Partners, CareMore, Atrius Health, and Heritage have been operating under full-risk and global capitation models for decades. They didn't just talk about accountability—they owned it. They took financial and clinical responsibility for patient populations, investing in care models that emphasized prevention, coordination, and personalization.
The principles of value-based care aren't novel. The label is.
And what about ethnic-focused health plans—a 'new' trend in culturally competent care? Again, the industry is rediscovering what others have quietly mastered for years. Plans like the Chinese Community Health Plan, Central Health Plan of California, and Brand New Day were designed from the ground up to serve specific populations, offering linguistically appropriate services and culturally attuned care models. They were responding to unmet needs.
The point isn't to diminish today's efforts—it's to root them in reality.
Because here's the danger: when we erase history in the name of innovation, we lose the lessons that history has to offer. We lose sight of what's been tried, what's worked, what's failed, and—most critically—why. We risk repeating mistakes not out of malice or ignorance, but out of amnesia.
Healthcare doesn't suffer from a shortage of ideas. It suffers from a shortage of execution and institutional memory. The most important breakthroughs don't come from pretending we're starting from scratch; they come from building on what already exists—with humility, discipline, and relentless improvement.
That's why I believe healthcare's true innovators are not always the ones with the slickest pitch decks or the most followers on X. They're the ones doing the hard, unglamorous work of refining, iterating, and executing better than those before them—because they studied those who came before them.
To move healthcare forward, we must respect where we've been. We must stop fetishizing novelty and start celebrating progress—however incremental it may be. Innovation isn't about renaming the past. It's about improving on it.
So the next time you hear someone claim they're the first to do something in healthcare, ask them to name their predecessors. If they can't, be skeptical.
Because in this business, those who ignore history aren't just doomed to repeat it—they're doomed to think they're innovating when they're simply rebranding.
And in healthcare, where lives and livelihoods are at stake, that's not just a missed opportunity—it's a serious liability.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealthcare lawsuit accuses Guardian of trying to ‘capitalize' on CEO's killing
UnitedHealthcare lawsuit accuses Guardian of trying to ‘capitalize' on CEO's killing

Yahoo

time14 minutes ago

  • Yahoo

UnitedHealthcare lawsuit accuses Guardian of trying to ‘capitalize' on CEO's killing

UnitedHealthcare is suing The Guardian for defamation over a story the publication ran related to its billing for nursing home residents. In a May 21 story, The Guardian US alleged that the health care giant saved money at the cost of nursing home residents' health. In a lawsuit filed on Wednesday, UnitedHealthcare said that The Guardian had knowingly published false information, and tried to capitalize on media interest in the killing of its then-CEO last year in New York. The health care company alleged that The Guardian cropped screenshots quoted in the article, taking the email out of its full context. It further disputed some of The Guardian's characterizations of medical events in the story. 'The Guardian knew these accusations were false, but published them anyway, brazenly trying to capitalize on the tragic and shocking assassination of UnitedHealthcare's then-CEO, Brian Thompson,' the complaint says. UnitedHealthcare is being represented by the law firm Clare Locke, which has made a name for itself for aggressively pursuing defamation lawsuits against news media organizations. In a fiery statement first shared with Semafor, The Guardian said it was not backing down from its reporting following the lawsuit, saying that the story was backed up by documents and on-the-record lawsuits. 'The Guardian stands by its deeply-sourced, independent reporting, which is based on thousands of corporate and patient records, publicly filed lawsuits, declarations submitted to federal and state agencies, and interviews with more than 20 current and former UnitedHealth employees — as well as statements and information provided by UnitedHealth itself over several weeks,' a spokesperson said. 'It's outrageous that in response to factual reporting on the practice of secretly paying nursing homes to reduce hospitalizations for vulnerable patients, UnitedHealth is resorting to wildly misleading claims and intimidation tactics via the courts.' UnitedHealth has struggled in the months since the high-profile murder of its former CEO. Last month, the company announced that it was replacing its now-former CEO, Andrew Witty, after reporting poor profits and shaky projections for the rest of 2025. And The Wall Street Journal reported that the company is at the center of multiple Department of Justice investigations for potential Medicare fraud. Investors in UHC sued the company last month, alleging it had not adjusted its earnings outlook to account for the killing of Thompson. Luigi Mangione, the man accused of killing Thompson, has asked that his New York murder charge be dropped on the grounds that the ongoing federal case against him amounts to double jeopardy. His lawyers have also asked that he not be required to wear shackles or a bulletproof vest to court.

Chinese researchers' alleged plot to smuggle crop-killing fungus into US is an ‘attack on US food supply': feds
Chinese researchers' alleged plot to smuggle crop-killing fungus into US is an ‘attack on US food supply': feds

New York Post

timean hour ago

  • New York Post

Chinese researchers' alleged plot to smuggle crop-killing fungus into US is an ‘attack on US food supply': feds

National security authorities and members of Congress are raising alarm over the alleged plot by two romantically involved Chinese researchers to smuggle samples of a dangerous crop-killing fungus into the US. Yunquing Jian, 33, a Communist Party loyalist and lab researcher at the University of Michigan who received Chinese government funding for her work, plotted the illicit transport of the pathogen with her boyfriend, Zunyong Liu, 34, the FBI alleged. Liu was was caught at Detroit Metropolitan Airport last July after allegedly attempting to sneak packages of Fusarium graminearum into the country, the feds said. 'This is an attack on the American food supply,' one senior Trump administration official told The Post. Advertisement 4 Yunqing Jian (pictured) initially denied that she was aware of her boyfriend's intent to smuggle the pathogen. University of Michigan The fungus is already present in the US, but if it was manipulated to become resistant to treatment or to spread more easily, it could have the potential to devastate American farms, one expert told The Post. The US should be testing the fungus sample for any evidence it's been tampered with, the expert added. There are similar allegations that the virus that causes COVID-19 was enhanced by China's Wuhan Institute of Virology as part of US-funded 'gain-of-function' research of the naturally occurring SARS pathogen. China denies that COVID leaked from the lab, but US intel agencies now say that appears to be the most likely cause of the pandemic. Advertisement 'The CCP will use every tool in its warfare toolbox to cripple the United States and bring us to our knees. A pathogen like this, if successfully introduced into a crop, could inflict significant economic loss for U.S. agriculture producers,' House Intelligence Committee Chairman Rick Crawford (R-Ark.) told The Post. Sen. Joni Ernst (R-Iowa) said it appears the FBI may have intercepted a 'potential bioweapon.' 'We are very fortunate the Trump administration and federal law enforcement stopped this potential bioweapon before it compromised our nation's food supply,' Ernst told The Post. 4 Chinese national Yunqing Jian, 33, a University of Michigan lab researcher, is charged with her fellow researcher boyfriend, Zunyong Liu, of conspiring to smuggle a potentially dangerous fungal pathogen into the US. Sanilac County Jail Advertisement 'This is exactly why I have always said and will continue to say – food security is national security. Between this latest bioweapon and China's highly-concerning purchases of U.S. farmland around our military bases, we must stay on guard against the threat from Communist China in our own backyard.' According to the feds, the Chinese couple discussed how they could smuggle Fusarium graminearum into the US — a biological pathogen considered 'a potential agroterrorism weapon' capable of destroying crops and poisoning both livestock and humans, according to a criminal complaint filed in federal court in Michigan Monday. Both Jian and Liu were charged Monday in a federal criminal complaint with conspiracy, smuggling goods into the US, false statements and visa fraud. 'The bacteria infects wheat, barley, corn and rice. When it does, it can devastate crops,' one national security source who specializes in agricultural microbiology told The Post. Advertisement 'The key question is if the bacterial strain being brought in has been modified to make it resistant to treatment or to make it more pathogenic.' 4 Liu was caught at Detroit Metropolitan Airport last July with four plastic baggies containing 'fibrous material' infected with the pathogen. AP The source added that it could be dangerous 'if the Chinese manipulated the strain' and that federal investigators should 'have a genome sequence done' on the samples Jian and Liu allegedly conspired to smuggle into the country. On July 27, 2024, Liu, who works as a researcher at Zhejiang University in Hangzhou, arrived in Detroit on a Delta flight from Shanghai and was interviewed by Customs and Border Patrol agents about the purpose of his travel. He claimed he was in the US to visit Jian, a lab researcher at the University of Michigan whom he identified as his girlfriend. Upon searching his belongings, agents found four plastic baggies containing 'fibrous material' infected with the pathogen, as well as a round piece of filter paper with a series of circles drawn on it, concealed in his backpack in a ball of wadded up tissues. According to the criminal complaint, Liu initially denied the items were his, suggesting someone else had put them into his bag without his knowledge. However he later admitted they were different strains of Fusarium graminearum he intended to research at the Molecular Plant-Microbe Interaction (MPMI) Laboratory at the University of Michigan, where Jian conducts research on similar pathogens. He also acknowledged he hid the materials when traveling to the US because he knew border patrol agents would confiscate them if they were discovered. Advertisement The circled filter paper found in his possession contained 10 separate coded samples, including one that 'would allow a researcher to propagate live Fusarium graminearum,' the complaint states. Liu told investigators that he planned to clone the different strains and make more samples if the experiments on the bagged materials failed. He was denied entry into the US and fast-tracked for removal to China. While searching one of Liu's cell phones, they found an article in PDF form titled '2018 Plant-Pathogen Warfare under Changing Climate Conditions.' Authorities said the article specifically referenced Fusarium graminearum as 'an example of a destructive disease and pathogen for crops' and is 'responsible for billions of dollars in economic losses worldwide each year.' 4 Fusarium graminearum can have a devastating effect on staple US crops including wheat, barley, corn and rice. AP Advertisement The FBI interviewed Jian at the MPMI Laboratory in February, where she first claimed she only learned of the alleged smuggling scheme when Liu was caught by CBP, and denied assisting him in his research of Fusarium graminearum. Upon searching Jian's cell phone, the FBI said it discovered a document she signed originating from Zhejiang University, where Liu conducts research on the pathogen, which included a loyalty pledge to 'adhere to the four basic principles' and 'support the leadership of the Communist Party of China.' FBI Special Agent Edward Nieh said in his affidavit that one of the principles Jian signed her allegiance to includes 'upholding Mao Zedong thought and Marxism-Leninism.' Investigators said she signed the document Jan. 11, 2024, just six months before Liu allegedly flew to Detroit with the samples in tow. Advertisement Further investigation into Liu and Jian's communications indicate it wasn't the first time the pair had discussed smuggling the fetid fungus into the US. One unearthed exchange from Aug. 12, 2022 on the Chinese messaging app WeChat reveals the couple scheming on how to sneak the seeds past US customs officials, with Liu advising Jian to hid the materials in her shoes. A day later, Jian arrived at San Francisco International Airport on a United Airlines flight from Seoul. Authorities reviewed records from her entry and found she did not declare she was importing any biological materials. Rutgers University molecular biologist Dr. Richard Ebright told The Post that Fusarium graminearum causes estimated losses of $200-400 million to US agriculture every year. Advertisement However, he said, the fungus has been endemic in the US for more than 40 years, and that new introduction of the organism into the US does not, by itself, pose a new threat. 'Importation of Fusarium graminearum without a USDA PPQ526 permit should not have occurred,' he said. 'However, unless the imported strain was a new strain having enhanced transmissibility or virulence, its importation likely posed no threat to US agriculture or US security,' he added, noting that if Jian had gone through proper permitting procedure to obtain the pathogen, it 'almost certainly would have been approved and arrests would not have occurred.' Jian, who received a J1 visa to conduct research as a postdoctoral scholar at a University of Texas lab, was a postdoctoral fellow at the University of Michigan before being offered a job in August 2023. The University of Michigan did not respond to The Post's questions about whether she is still employed there following the allegations. The Post also reached out to Jian at her university email address but did not hear back. Liu secured a B2 tourist visa in March 2024, which does not allow foreign nationals to perform work or scientific research during their visit. Jian was temporarily detained by authorities on June 3 until her detention hearing scheduled for Thursday at 1 p.m. Her case has been assigned to the public defender's office but an attorney had not been named by Wednesday evening. Liu remains at large with a warrant out for his arrest.

Medicaid Is Overdue for a Big Beautiful Overhaul
Medicaid Is Overdue for a Big Beautiful Overhaul

Wall Street Journal

time3 hours ago

  • Wall Street Journal

Medicaid Is Overdue for a Big Beautiful Overhaul

National health-insurance coverage has been a top priority for the American left for decades. Medicaid has been the main vehicle for reaching this goal since 1965. The program now accounts for more than half of the 150 million Americans covered by government health insurance. President Trump's 'big, beautiful bill' presents the Senate with a choice: Continue on the path toward national health insurance by locking in recent Medicaid expansions, or reform Medicaid and reverse course. After the defeat of President Harry Truman's national health-insurance plan in 1949, Democrats began an incremental journey. Medicare for seniors and Medicaid mainly for state welfare recipients were their first major steps. After Medicare was extended to the disabled in 1972, Democrats turned their attention to expanding Medicaid.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store